# US 2005/0038673 A1 · Method and system for automated pharmaceutical research and reporting

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0038673 A1
- Document ID: US20050038673A1
- Status: Published application
- Kind: A1
- Application number: 10/779,020
- Filed: 2004-02-13
- Published: 2005-02-17
- Earliest claimed: 2003-02-14
- Assignees: Precerche, Inc.
- Inventors: Tad Stookey; Steven Bergeron
- Web page: https://patentgrep.com/patent/US20050038673A1

## CPC

- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A system for automated management of a clinical trial for pharmaceutical, biomedical, and medical device development that facilitates pharmaceutical research and reporting, including at least one site server 222, at least one computing device 218 configured to collect primary clinical trial data, and an authorized user accessible computing device 234. The central server 232 is configured to receive the primary clinical trial data from each site server 222, to store the primary clinical trial data, to create secondary clinical trial data based on the primary clinical trial data, and to transmit the primary and secondary clinical trial data to the authorized user accessible computing device 234. Also provided is a method for automatically managing a clinical trial for pharmaceutical, biomedical, and medical device development in order to facilitate pharmaceutical research and reporting, which further includes a computer readable signal containing a set of instructions to perform a corresponding method.

## Claims

### Claim 1

A system for automated management of a clinical trial for pharmaceutical development that facilitates pharmaceutical research and reporting, comprising:
at least one site server each being associated with and communicably coupled to at least one computing device configured to collect primary clinical trial data using electronic data capture by providing interfaces through which users can enter data;
a central server communicably coupled via a network to each site server and communicably coupled via said network to an authorized user accessible computing device;
wherein each computing device configured to collect primary clinical trial data is adapted to validate data entered;
wherein each site server is configured to transmit the primary clinical trial data to the central server;
wherein the central server is configured:
to receive the primary clinical trial data from each site server;
to store the primary clinical trial data;
to create secondary clinical trial data based on the primary clinical trial data;
to transmit the primary and secondary clinical trial data to the authorized user accessible computing device.

### Claim 2 (depends on 1)

The system of claim 1, wherein the primary clinical trial data comprises patient information.

### Claim 3 (depends on 1)

The system of claim 1, wherein the secondary clinical trial data comprises a full audit trail.

### Claim 4 (depends on 1)

The system of claim 1, wherein the secondary clinical trial data comprises study metrics created based on the primary clinical trial data through algorithmic analysis of said primary clinical trial data.

### Claim 5 (depends on 1)

The system of claim 1, wherein the central server is further configured:
to transmit “same day” reports to the authorized user accessible computing device.

### Claim 6 (depends on 1)

The system of claim 1, wherein the central server is further configured:
to transmit data to the authorized user accessible computing device that allows an authorized user using the authorized user accessible computing device to manage inventory associated with the managed clinical trial.

### Claim 7 (depends on 1)

The system of claim 1, wherein the central server is further configured:
to transmit data to the authorized user accessible computing device that allows an authorized user using the authorized user accessible computing device to conduct online monitoring and audits of the managed clinical trial.

### Claim 8 (depends on 1)

The system of claim 1, wherein said network further comprises a full-time, public access network and further comprising a central server communicably coupled via a full-time, public access network to each site server and communicably coupled via said full-time, public access network to an authorized user accessible computing device

### Claim 9 (depends on 8)

The system of claim 8, wherein said full-time, public access network further comprises a secure channel and further comprising a central server communicably coupled via a full-time, public access network using a secure channel to each site server and communicably coupled via said full-time, public access network through said a secure channel to an authorized user accessible computing device

### Claim 10

A method for automatically managing a clinical trial for pharmaceutical development in order to facilitate pharmaceutical research and reporting, comprising the steps of:
capturing electronic data corresponding to primary clinical trial data by the use by a user of a computing device configured with interfaces adapted to collect primary clinical trial data;
validating the electronic data;
distributing across a full-time, public network the electronic data after said data has been validated from the corresponding computing device to a central server;
creating secondary clinical trial data based on the primary clinical trial data;
storing the primary and secondary clinical trial data; and
making said stored primary and secondary clinical trial data available by the central server to be accessed across the full-time, public network by an authorized user accessible computing device.

### Claim 11 (depends on 10)

The method of claim 10, wherein the step of capturing electronic data corresponding to primary clinical trial data by the use by the user of the computing device configured with interfaces adapted to collect primary clinical trial data comprises the step of:
capturing electronic data corresponding to patient information by the use by a user of a computing device configured with interfaces adapted to collect patient information.

### Claim 12 (depends on 10)

The method of claim 10, wherein the step of creating secondary clinical trial data based on the primary clinical trial data comprises the step of:
creating a full audit trail based on the primary clinical trial data.

### Claim 13 (depends on 10)

The method of claim 10, wherein the step of creating secondary clinical trial data based on the primary clinical trial data comprises the step of:
creating study metrics based on the primary clinical trial data through algorithmic analysis of said clinical trial data.

### Claim 14 (depends on 10)

The method of claim 10, wherein the step of making said stored primary and secondary clinical trial data available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device comprises the step of:
making “same day” reports available by the central server to be accessed across a full-time, public network by the authorized user accessible computing device.

### Claim 15 (depends on 10)

The method of claim 10, wherein the step of making said stored primary and secondary clinical trial data available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device comprises the step of:
making said stored primary and secondary clinical trial data sufficiently available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device, thereby allowing an authorized user using the authorized user accessible computing device to manage inventory associated with the managed clinical trial.

### Claim 16 (depends on 10)

The method of claim 10, wherein the step of making said stored primary and secondary clinical trial data available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device comprises the step of:
making said stored primary and secondary clinical trial data sufficiently available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device, thereby allowing an authorized user using the authorized user accessible computing device to conduct online monitoring and audits of the managed clinical trial.

### Claim 17

A computer-readable signal capable of being propagated between computers and which contains a set of instructions for a general purpose computer having a user interface comprising a mouse and a screen display, the set of instructions comprising:
an input routine operatively associated with said user interface for permitting a user to select an icon displayed on said screen display with said mouse, said icon associated with an applications program accessible to said computer;
wherein execution of the applications program performs a method for automatically managing a clinical trial for pharmaceutical development in order to facilitate pharmaceutical research and reporting, comprising the steps of:
capturing electronic data corresponding to primary clinical trial data by the use by a user of a computing device configured with interfaces adapted to collect primary clinical trial data;
validating the electronic data;
distributing across a full-time, public network the electronic data after said data has been validated from the corresponding computing device to a central server;
creating secondary clinical trial data based on the primary clinical trial data;
storing the primary and secondary clinical trial data; and
making said stored primary and secondary clinical trial data available by the central server to be accessed across the full-time, public network by an authorized user accessible computing device.
a run routine for executing said applications program selected by the user with said mouse; and
a display routine responsive to said run routine for displaying on said screen display text or images generated by said applications program.

### Claim 18 (depends on 17)

The signal of claim 17, wherein the step of capturing electronic data corresponding to primary clinical trial data by the use by the user of the computing device configured with interfaces adapted to collect primary clinical trial data comprises the step of:
capturing electronic data corresponding to patient information by the use by a user of a computing device configured with interfaces adapted to collect patient information.

### Claim 19 (depends on 17)

The signal of claim 17, wherein the step of creating secondary clinical trial data based on the primary clinical trial data comprises the step of:
creating study metrics based on the primary clinical trial data through algorithmic analysis of said clinical trial data.

### Claim 20 (depends on 17)

The signal of claim 17, wherein the step of making said stored primary and secondary clinical trial data available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device comprises the step of:
making said stored primary and secondary clinical trial data sufficiently available by the central server to be accessed across the full-time, public network by the authorized user accessible computing device, thereby allowing an authorized user using the authorized user accessible computing device to manage inventory associated with the managed clinical trial.
